Carlos F. Lagos retweeted
📷 DECLARACIÓN PÚBLICA: La dispensación de medicamentos debe resguardar la seguridad de los pacientes y cumplir la normativa sanitaria. Frente a las gestiones que Mercado Libre estaría realizando ante autoridades chilenas, las organizaciones firmantes declaran:
Carlos F. Lagos retweeted
Desde Valdivia, investigadores e investigadoras descubrieron un mecanismo clave en las neuronas. El estudio, financiado principalmente por @anid_chile; vía Fondecyt, y publicado en Cell Metabolism; ayuda a entender cómo las neuronas se protegen del estrés oxidativo, un tipo de daño celular vinculado a enfermedades como el Alzheimer, el Parkinson y los accidentes cerebrovasculares.
Este hallazgo abre nuevas líneas de investigación para comprender qué ocurre cuando estos mecanismos de protección fallan. 🔬
Carlos F. Lagos retweeted
🚨 BREAKING: IBM launches a free Python library that converts ANY document to data
Introducing Docling. Here's what you need to know: 🧵
Carlos F. Lagos retweeted
📢 ¡Ya está disponible el Calendario de Convocatorias 2026 de ANID! Conoce y planifica la postulación a oportunidades de financiamiento para proyectos individuales y asociativos en investigación, tecnología, innovación y estudios de postgrado. Revisa las fechas clave en: anid.cl/calendario-concursos…
Carlos F. Lagos retweeted
I'm Boris and I created Claude Code. I wanted to quickly share a few tips for using Claude Code, sourced directly from the Claude Code team. The way the team uses Claude is different than how I use it. Remember: there is no one right way to use Claude Code -- everyones' setup is different. You should experiment to see what works for you!
Carlos F. Lagos retweeted
Libgen, Sci-Hub, and Z-library had millions of pirated academic books and papers.
So, they were shut down. We shouldn't use them anyway.
We should help billion-dollar academic publishers get richer.
Anyway, here's how to access these libraries:
Don't do this!
Carlos F. Lagos retweeted
New Practical Cheminformatics Post, "Useful RDKit Utils - A Mötley Collection of Helpful Routines"
patwalters.github.io/Useful-…
Carlos F. Lagos retweeted
Wow, wow, wow!!!
The structure of human sweetness cell.com/cell/fulltext/S0092…
Carlos F. Lagos retweeted
For readers interested in siRNA therapies, here's a review nature.com/articles/s41573-0…
rdcu.be/ef9IV
Carlos F. Lagos retweeted
Yuuge paper on #psychedelics The structural diversity of psychedelic drug actions revealed nature.com/articles/s41467-0…
Carlos F. Lagos retweeted
Identifying ligands for therapeutic targets among billions of compounds is challenging! Can we search ultra-large chemical libraries more efficiently?
Yes! Read about our docking/ML approach:
nature.com/articles/s43588-0…
Carlos F. Lagos retweeted
For readers interested in RNA-based medicines such as antisense oligonucleotides and siRNAs, here's a review discussing strategies to address challenges associated with their applicability, efficacy and safety profiles
nature.com/articles/s41573-0…
rdcu.be/eciEq
Carlos F. Lagos retweeted
Solo falta el 10%....muy muy cerca de la meta!!!
Aun puedes ADQUIRIR TU ENTRADA PARA MAÑANA O HACER TU DONACIÓN
crowdfunding.4id.science/
🗓️ *Sábado 1 de marzo*
⏰ *Entre 12 y 20 horas*
📍 *Villa Rovereto, Laguna de Aculeo, Paine*
Te esperamos!
Carlos F. Lagos retweeted
El último día de febrero se conmemora el día mundial de las #EnfermedadesRaras #PocoFrecuentes @rarediseaseday . En preparación para este día, compartiremos durante esta semana los resultados principales de nuestro trabajo de investigación colaborativa en el @ICIM_UDD et al.
Carlos F. Lagos retweeted
For readers interested in personalized therapeutics such as antisense oligonucleotides for ultra-rare diseases, this review from @irdirc discusses progress in the field and provides a roadmap for their development
nature.com/articles/s41573-0…
rdcu.be/ea4yG
Carlos F. Lagos retweeted
For readers interested in cancer immunotherapy, this Review in our February issue discusses opportunties and challenges in using vaccines for cancer prevention
nature.com/articles/s41573-0…
rdcu.be/eaNxo
Carlos F. Lagos retweeted
For readers interested in therapeutic strategies for Duchenne muscular dystrophy, here's a review
nature.com/articles/s41573-0…
rdcu.be/eaGft
Carlos F. Lagos retweeted
For readers interested in new epilepsy therapies in development, here's a comprehensive recent review
nature.com/articles/s41573-0…
rdcu.be/eaxv6

























